Artificial Tears Study in Mild to Moderate Dry Eye Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

January 31, 2007

Study Completion Date

April 30, 2007

Conditions

Dry Eye

Interventions

DRUG

(9587X) Blink Tears, classified as an OTC Drug with the active ingredient being plyethylene glycol 400

Drops

DRUG

Systane

Drops

All Listed Sponsors

lead

Abbott Medical Optics

INDUSTRY

NCT00607776 - Artificial Tears Study in Mild to Moderate Dry Eye Patients | Biotech Hunter | Biotech Hunter